We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications.
MONTREAL and CHARLOTTE, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (“Milestone”) (Nasdaq: MIST), a biopharmaceutical company focused on the development and...
MONTREAL and CHARLOTTE, N.C., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (“Milestone”) (Nasdaq: MIST), a biopharmaceutical company focused on the development and...
By Denny Jacob Milestone Pharmaceuticals shares sank 24% to $2.20 in premarket trading after it received a refusal to file letter from the Food and Drug Administration. The stock is down 27% on...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.09 | 5.625 | 1.6 | 1.71 | 1.505 | 224211 | 1.58782791 | CS |
4 | -0.07 | -3.97727272727 | 1.76 | 1.85 | 1.5 | 164562 | 1.66802983 | CS |
12 | 0.04 | 2.42424242424 | 1.65 | 2.4 | 1.36 | 345751 | 1.72742589 | CS |
26 | -1.16 | -40.701754386 | 2.85 | 3.52 | 1.33 | 311952 | 1.93164728 | CS |
52 | -1.84 | -52.1246458924 | 3.53 | 4.49 | 1.33 | 204885 | 2.26536141 | CS |
156 | -4.21 | -71.3559322034 | 5.9 | 9.8465 | 1.33 | 184014 | 4.5075419 | CS |
260 | -13.92 | -89.1736066624 | 15.61 | 27.95 | 1.33 | 494614 | 6.48384505 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions